Former French Open finalist Sara Errani, who has been handed a two-month doping ban, has insisted that she is not a cheat.
The 30-year-old Italian tested positive for the cancer treatment drug letrozole, which can increase body mass, in February following which the International Tennis Federation announced the suspension on Monday,
At a news conference on Wednesday, Errani continued to blame food contamination and said that she would return "stronger than ever" and that "it's a difficult situation" for her family "but we have managed to be even more united so I'm proud of them", reports Sport24.
The former world number five also said, "I know I have done nothing wrong."
Eranni has reiterated several times that letrozole is not a performance-enhancing drug.
The ban of the current 98-ranked player will end on October 2.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app